T. Rowe Price Associates’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-353,877
| Closed | -$26.8M | – | 3285 |
|
|
2026
Q1 | $26.8M | Sell |
353,877
-8,796
| -2% | -$661K | ﹤0.01% | 969 |
|
|
2025
Q4 | $27M | Buy |
362,673
+9,196
| +3% | +$672K | ﹤0.01% | 986 |
|
|
2025
Q3 | $23.9M | Buy |
353,477
+3,344
| +1% | +$222K | ﹤0.01% | 1017 |
|
|
2025
Q2 | $22.8M | Sell |
350,133
-22,958
| -6% | -$1.38M | ﹤0.01% | 935 |
|
|
2025
Q1 | $23M | Sell |
373,091
-856,764
| -70% | -$56.8M | ﹤0.01% | 923 |
|
|
2024
Q4 | $88.7M | Sell |
1,229,855
-1,572,074
| -56% | -$123M | 0.01% | 592 |
|
|
2024
Q3 | $228M | Sell |
2,801,929
-3,074,246
| -52% | -$246M | 0.03% | 414 |
|
|
2024
Q2 | $436M | Sell |
5,876,175
-421,022
| -7% | -$31.6M | 0.05% | 297 |
|
|
2024
Q1 | $491M | Buy |
6,297,197
+2,753,016
| +78% | +$205M | 0.06% | 277 |
|
|
2023
Q4 | $253M | Buy |
3,544,181
+369,812
| +12% | +$25.7M | 0.03% | 373 |
|
|
2023
Q3 | $220M | Buy |
3,174,369
+921,962
| +41% | +$69.7M | 0.03% | 374 |
|
|
2023
Q2 | $182M | Sell |
2,252,407
-343,065
| -13% | -$28M | 0.03% | 405 |
|
|
2023
Q1 | $209M | Sell |
2,595,472
-1,808,176
| -41% | -$146M | 0.03% | 374 |
|
|
2022
Q4 | $329M | Sell |
4,403,648
-2,849,880
| -39% | -$203M | 0.05% | 295 |
|
|
2022
Q3 | $468M | Sell |
7,253,528
-27,431,310
| -79% | -$1.9B | 0.08% | 236 |
|
|
2022
Q2 | $2.4B | Sell |
34,684,838
-8,421,942
| -20% | -$625M | 0.3% | 59 |
|
|
2022
Q1 | $3.31B | Buy |
43,106,780
+1,810,119
| +4% | +$130M | 0.33% | 59 |
|
|
2021
Q4 | $3.16B | Sell |
41,296,661
-650,617
| -2% | -$47.8M | 0.28% | 70 |
|
|
2021
Q3 | $3.1B | Buy |
41,947,278
+4,430,518
| +12% | +$332M | 0.29% | 70 |
|
|
2021
Q2 | $2.5B | Sell |
37,516,760
-1,064,558
| -3% | -$71.2M | 0.23% | 92 |
|
|
2021
Q1 | $2.87B | Sell |
38,581,318
-688,874
| -2% | -$52.3M | 0.29% | 71 |
|
|
2020
Q4 | $2.86B | Sell |
39,270,192
-2,031,073
| -5% | -$143M | 0.29% | 68 |
|
|
2020
Q3 | $2.75B | Sell |
41,301,265
-1,428,190
| -3% | -$90.4M | 0.32% | 60 |
|
|
2020
Q2 | $2.44B | Sell |
42,729,455
-1,167,402
| -3% | -$57.3M | 0.31% | 65 |
|
|
2020
Q1 | $1.54B | Sell |
43,896,857
-196,848
| -0.4% | -$9.37M | 0.24% | 89 |
|
|
2019
Q4 | $2.3B | Buy |
44,093,705
+1,928,210
| +5% | +$96M | 0.3% | 69 |
|
|
2019
Q3 | $2.13B | Sell |
42,165,495
-31,668
| -0.1% | -$1.56M | 0.3% | 74 |
|
|
2019
Q2 | $2.03B | Buy |
42,197,163
+116,925
| +0.3% | +$5.41M | 0.28% | 82 |
|
|
2019
Q1 | $2.04B | Sell |
42,080,238
-912,235
| -2% | -$41.1M | 0.3% | 75 |
|
|
2018
Q4 | $1.77B | Sell |
42,992,473
-3,605,248
| -8% | -$148M | 0.3% | 79 |
|
|
2018
Q3 | $1.91B | Sell |
46,597,721
-455,778
| -1% | -$18.4M | 0.28% | 82 |
|
|
2018
Q2 | $1.87B | Sell |
47,053,499
-398,791
| -0.8% | -$15.3M | 0.29% | 78 |
|
|
2018
Q1 | $1.77B | Buy |
47,452,290
+2,250,251
| +5% | +$90.9M | 0.28% | 79 |
|
|
2017
Q4 | $1.93B | Buy |
45,202,039
+1,195,214
| +3% | +$47.7M | 0.31% | 73 |
|
|
2017
Q3 | $1.61B | Buy |
44,006,825
+2,192,094
| +5% | +$88.5M | 0.28% | 85 |
|
|
2017
Q2 | $1.9B | Sell |
41,814,731
-2,600,946
| -6% | -$115M | 0.34% | 69 |
|
|
2017
Q1 | $1.89B | Buy |
44,415,677
+1,091,863
| +3% | +$44.5M | 0.35% | 64 |
|
|
2016
Q4 | $1.74B | Buy |
43,323,814
+2,015,135
| +5% | +$77.8M | 0.35% | 72 |
|
|
2016
Q3 | $1.6B | Buy |
41,308,679
+4,729,190
| +13% | +$179M | 0.32% | 70 |
|
|
2016
Q2 | $1.27B | Buy |
36,579,489
+15,159,949
| +71% | +$525M | 0.27% | 87 |
|
|
2016
Q1 | $739M | Buy |
21,419,540
+5,646,169
| +36% | +$197M | 0.16% | 163 |
|
|
2015
Q4 | $610M | Buy |
15,773,371
+360,928
| +2% | +$14M | 0.13% | 182 |
|
|
2015
Q3 | $603M | Buy |
15,412,443
+2,082,343
| +16% | +$82.6M | 0.13% | 181 |
|
|
2015
Q2 | $507M | Buy |
13,330,100
+4,440,820
| +50% | +$155M | 0.1% | 226 |
|
|
2015
Q1 | $294M | Buy |
8,889,280
+254,969
| +3% | +$7.83M | 0.06% | 354 |
|
|
2014
Q4 | $231M | Buy |
8,634,311
+1,916,080
| +29% | +$49.5M | 0.05% | 393 |
|
|
2014
Q3 | $163M | Buy |
6,718,231
+1,125,200
| +20% | +$28.4M | 0.04% | 471 |
|
|
2014
Q2 | $142M | Buy |
5,593,031
+2,451,233
| +78% | +$57.3M | 0.03% | 536 |
|
|
2014
Q1 | $67.5M | Buy |
3,141,798
+3,048,900
| +3,282% | +$65.8M | 0.02% | 760 |
|
|
2013
Q4 | $2.08M | Hold |
92,898
| – | – | ﹤0.01% | 1535 |
|
|
2013
Q3 | $1.92M | Sell |
92,898
-4,200
| -4% | -$89.4K | ﹤0.01% | 1554 |
|
|
2013
Q2 | $1.87M | Buy |
+97,098
| New | +$2.03M | ﹤0.01% | 1533 |
|
Other funds holding HOLX
T. Rowe Price Associates's HOLX Position: Q2 2026 in Review
T. Rowe Price Associates sold out of Hologic (HOLX) in Q2 2026, closing a stake of 353,877 shares — an estimated $26.8M sold.
T. Rowe Price Associates first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $3.31B in Q1 2022. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- T. Rowe Price Associates reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- T. Rowe Price Associates sold 353,877 Hologic shares in Q2 2026, an estimated $26.8M.
- T. Rowe Price Associates first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
- T. Rowe Price Associates's Hologic position peaked at $3.31B in Q1 2022.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.